Matthijs Gert, Souche Erika, Alders Mariëlle, Corveleyn Anniek, Eck Sebastian, Feenstra Ilse, Race Valérie, Sistermans Erik, Sturm Marc, Weiss Marjan, Yntema Helger, Bakker Egbert, Scheffer Hans, Bauer Peter
Center for Human Genetics, KU Leuven, Gasthuisberg, Laboratory for Molecular Diagnosis, Leuven, Belgium.
Department of Clinical Genetics, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam, The Netherlands.
Eur J Hum Genet. 2016 Jan;24(1):2-5. doi: 10.1038/ejhg.2015.226. Epub 2015 Oct 28.
We present, on behalf of EuroGentest and the European Society of Human Genetics, guidelines for the evaluation and validation of next-generation sequencing (NGS) applications for the diagnosis of genetic disorders. The work was performed by a group of laboratory geneticists and bioinformaticians, and discussed with clinical geneticists, industry and patients' representatives, and other stakeholders in the field of human genetics. The statements that were written during the elaboration of the guidelines are presented here. The background document and full guidelines are available as supplementary material. They include many examples to assist the laboratories in the implementation of NGS and accreditation of this service. The work and ideas presented by others in guidelines that have emerged elsewhere in the course of the past few years were also considered and are acknowledged in the full text. Interestingly, a few new insights that have not been cited before have emerged during the preparation of the guidelines. The most important new feature is the presentation of a 'rating system' for NGS-based diagnostic tests. The guidelines and statements have been applauded by the genetic diagnostic community, and thus seem to be valuable for the harmonization and quality assurance of NGS diagnostics in Europe.
我们代表欧洲基因检测联盟(EuroGentest)和欧洲人类遗传学学会,发布关于评估和验证用于诊断遗传疾病的新一代测序(NGS)应用的指南。这项工作由一组实验室遗传学家和生物信息学家完成,并与临床遗传学家、行业代表、患者代表以及人类遗传学领域的其他利益相关者进行了讨论。在此展示制定指南过程中所撰写的声明。背景文件和完整指南可作为补充材料获取。其中包含许多示例,以协助实验室实施NGS并对该服务进行认证。过去几年中其他地方出现的指南中他人提出的工作和观点也在制定过程中得到了考虑,并在全文中予以认可。有趣的是,在制定指南过程中出现了一些此前未被引用的新见解。最重要的新特性是为基于NGS的诊断测试提出了一种“评级系统”。这些指南和声明受到了基因诊断界的欢迎,因此似乎对欧洲NGS诊断的协调和质量保证具有重要价值。